Latisse ™

The first and only FDA-approved lash treatment

LATISSE™ (bimatoprost ophthalmic solution) 0.03% is the first and only prescription treatment approved by the FDA for inadequate or not having enough eyelashes, growing them longer, fuller and darker.

LATISSE™ makes lash growth possible because of its active ingredient: bimatoprost. Although the precise mechanism of action is not known, research suggests that the growth of eyelashes occurs by increasing the percent of hairs in, and the duration of, the anagen (or growth) phase. Lashes can grow longer, thicker and darker because bimatoprost can also prolong this growth phase.

Dr. Joette Gracia-Trujillo performs all Latisse treatments in her office. The procedure time may vary. Call to schedule an appointment with Dr. Gracia-Trujillo to see whether Latisse is right for you!

Safety Information

LATISSE™ is an FDA-approved prescription treatment for hypotrichosis used to grow eyelashes, making them longer, thicker and darker. Hypotrichosis is another name for having inadequate or not enough eyelashes. The FDA reviewed clinical study results to verify the identity, potency, purity and stability of the ingredients, and demonstrated that the product is safe and effective for its intended use if used as prescribed..


Latisse

Easy online Complimentary Consultation appointments.